DAILY DOSE: Personalized mRNA Vaccine Shows Promise Against Melanoma; China Tests Chemogenetic Brain Therapies in Humans.

Moderna and Merck's personalized mRNA vaccine improves melanoma survival outcomes in a Phase 3 trial. Other studies highlight advances in brain therapies, thought processes, and neurological mechanisms in diverse conditions.